Weiwei Chen
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Surgical Treatments 5
- Colorectal Cancer Treatments and Studies 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Shaohui Tang (9 shared papers)Hao Yu (1 shared paper)Yuzhu Hou (1 shared paper)Xin‐Yuan Guan (1 shared paper)Yan Zhang (1 shared paper)Timothy Shun Man Chu (1 shared paper)Shaowei Dong (1 shared paper)Liangliang Xu (1 shared paper)
- Journals
- World Journal of Surgical Oncology (2 papers)Frontiers in Oncology (2 papers)Journal of Hypertension (1 paper)Technology in Cancer Research & Treatment (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weiwei Chen
41 papers receiving 439 citations
Peers
Comparison fields: 5 of 93
- Oncology 203
- Immunology 109
- Cancer Research 54
- Pulmonary and Respiratory Medicine 63
- Nephrology 13
Countries citing papers authored by Weiwei Chen
This map shows the geographic impact of Weiwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Chen more than expected).
Fields of papers citing papers by Weiwei Chen
This network shows the impact of papers produced by Weiwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Chen. The network helps show where Weiwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 121 | |
| 2 | 2024 | 32 | |
| 3 | 2012 | 29 | |
| 4 | 2019 | 28 | |
| 5 | 2014 | 24 | |
| 6 | 2022 | 19 | |
| 7 | 2022 | 18 | |
| 8 | 2017 | 17 | |
| 9 | 2022 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 10 | |
| 14 | 2018 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2020 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2022 | 5 |
About Weiwei Chen
Weiwei Chen is a scholar working on Oncology, Molecular Biology, Physiology, Cancer Research and Surgery, having authored 43 papers that have together received 445 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Surgical Treatments (5 papers), Immunotherapy and Immune Responses (4 papers), Diet and metabolism studies (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Nutritional Studies and Diet (3 papers). The work is most often cited by research in Oncology (203 citations), Immunology (109 citations), Cancer Research (54 citations), Pulmonary and Respiratory Medicine (63 citations) and Nephrology (13 citations). Weiwei Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shaohui Tang, Hao Yu, Yuzhu Hou, Xin‐Yuan Guan, Yan Zhang, Timothy Shun Man Chu, Shaowei Dong, Liangliang Xu, Bo Li and Zhiyuan Xu. Their work appears in journals such as World Journal of Surgical Oncology, Frontiers in Oncology, Journal of Hypertension, Technology in Cancer Research & Treatment and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.